Aspira Women’s Health Inc. Notes Payable, Fair Value Disclosure
Aspira Women’s Health Inc. (AWHL) had Notes Payable, Fair Value Disclosure of $2.56 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:NotesPayableFairValueDisclosure · last filed 2026-08-14
- 2026-06-30: Notes Payable, Fair Value Disclosure $2.56M.
- 2026-03-31: Notes Payable, Fair Value Disclosure $2.56M.
- 2025-12-31: Notes Payable, Fair Value Disclosure $2.56M.
- 2025-09-30: Notes Payable, Fair Value Disclosure $2.56M.
| Period end | Notes Payable, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $2.56M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $2.56M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $2.56M 10-K · filed 2026-04-01 |
| 2025-09-30 | $2.56M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.56M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $2.56M 10-Q · filed 2025-05-19 |